REMI — Remedent Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Remedent, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2016 March 31st	2017 March 31st	2018 March 31st	2019 March 31st	2020 March 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.094	0.147	0.093	0.067	0.115
Net Total Accounts Receivable
Net Total Receivables	2.13	0.943	1.16	0.234	0.329
Total Inventory
Prepaid Expenses
Total Current Assets	2.86	1.28	1.67	0.656	0.681
Net Property, Plant And Equipment	0.411	0.274	0.144	0.126	0.067
Net Intangible Assets
Long Term Investments
Total Assets	5.7	4.73	5.44	7.9	7.51
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.43	1.55	2.13	2.43	2.88
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	3.52	1.62	2.21	2.5	2.96
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	2.18	3.11	3.23	5.39	4.55
Total Liabilities & Shareholders' Equity	5.7	4.73	5.44	7.9	7.51
Total Common Shares Outstanding